Funmilola Fisusi

Funmilola Fisusi is a Lecturer in Pharmaceutics at the School of Applied Sciences, University of Brighton. Previously, she held roles as a Research Fellow and Lecturer at Obafemi Awolowo University, Nigeria, and conducted postdoctoral research at Howard University, USA. Her expertise spans nanoparticle-based drug delivery for cancers, particularly breast and brain tumors, and the design of antimicrobial and anticancer peptides.

Education:

• PhD in Drug Delivery, University College London (2014)
• MSc in Pharmaceutics, Obafemi Awolowo University (2007)
• Bachelor of Pharmacy, Obafemi Awolowo University (2000)

Research Interests: Dr. Fisusi focuses on safe, targeted drug delivery systems using nanotechnology to enhance cancer therapy efficacy while minimizing side effects. She explores nanoparticle-based strategies for glioblastoma and breast cancer, as well as drug repurposing for combination therapies. Additionally, she develops peptide-based therapeutics with dual anticancer and antimicrobial properties.

Article Trends: Her publications emphasize nanoparticle formulations for drug delivery, including polymeric nanoparticles for breast cancer therapy and strategies to improve drug accumulation in tumors via the enhanced permeability and retention effect. She also investigates molecular mechanisms in diseases like cerebral malaria and explores plant-derived bioactive compounds for parasitic diseases.

Scientific Awards: None explicitly mentioned in the provided texts.

Advising & Grants: No formal advisees or grant details provided. Her research contributions focus on academic and biomedical applications of nanotechnology.

Labs/Teams: Affiliated with the School of Applied Sciences at the University of Brighton, contributing to interdisciplinary research in pharmaceutics and nanomedicine.